Article

Deep learning models reading clinical data and liver omics strongly distinguish NASH from steatosis and suggest new genes involved in liver disease severity

2025-10-10

Abstract excerpt

<h4>Background & Aims</h4> Metabolic dysfunction-associated steatotic liver disease (MASLD, previously NAFLD) is a frequent co-morbidity of obesity and diabetes, with prevalence increasing worldwide in all age groups and both sexes. Only early stages of the disease are fully reversible. Recognising liver disease stages and elucidating the molecular underpinning of their progression are thus medically important. W...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: eb736b18-5b3e-5e66-963c-7c4a1c627d2b
DOI: 10.1101/2025.10.10.681581

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Deep learning models reading clinical data and liver omics strongly distinguish NASH from steatosis and suggest new genes involved in liver disease severityDOI 10.1101/2025.10.10.681581Read

Integration of deep learning-based histopathology and transcriptomics reveals key genes associated with fibrogenesis in patients with advanced NASHSemantic proximity Read

Machine learning-based integration reveals reliable biomarkers and potential mechanisms of NASH progression to fibrosisSemantic proximity Read

Machine Learning Enables Single-Score Assessment of MASLD Presence and SeveritySemantic proximity Read

Application of Attention and Graph Transformer-Based Approaches for RNA Biomarker Discovery in Metabolically-Associated Fatty Liver Disease (MAFL/NASH)Semantic proximity Read

Identification of signature gene set as highly accurate determination of metabolic dysfunction-associated steatotic liver disease progressionSemantic proximity Read

Identification of Shared and Unique Key Biomarkers of Alcohol Liver Cirrhosis and Non-Alcoholic Steatohepatitis Through Machine Learning Network-Based AlgorithmsSemantic proximity Read

SteatoSITE: an Integrated Gene-to-Outcome Data Commons for Precision Medicine Research in NAFLDSemantic proximity Read

Identifying disease progression biomarkers in metabolic associated steatotic liver disease (MASLD) through weighted gene co-expression network analysis and machine learningSemantic proximity Read

Multiomics biomarkers for the prediction of nonalcoholic fatty liver disease severitySemantic proximity Read

A Proposed AI/ML-Based Detection Framework for Early Detection of Hepatocellular Carcinoma (HCC) and CirrhosisSemantic proximity Read

Machine Learning–Based Prediction of Ultrasound-Detected Metabolic Dysfunction–Associated Steatotic Liver Disease Using Routine Clinical and Biochemical ParametersSemantic proximity Read

Deep Learning based multi-omics integration robustly predicts survival in liver cancerSemantic proximity Read